|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Respiratory and Intensive Care Department (Drs. Cuvelier, Muir, Vavasseur, Portier, and Benhamou), Epidemiology Department (Dr. Czernichow), and Neurology Department (Dr. Samson-Dolfuss), Rouen University Hospital, Rouen, France.
Correspondence to: Antoine Cuvelier, MD, Respiratory and Intensive Care Department, Rouen University Hospital, 76031 Rouen cedex, France; e-mail: a-cuvelier{at}webmails.com
Objectives: We compared the efficacy of the standard nasal cannula and the demand oxygen delivery system (DODS) during sleep in patients with COPD.
Subjects: Twenty patients with moderate or severe COPD were included in the study.
Methods: Four consecutive polysomnographic recordings were
performed under the following conditions: DODS powered by compressed
air (night 1 [N1]); oxygen delivered with a nasal cannula alone
(night 2 [N2]); oxygen delivered through a DODS (night 3 [N3]); and
oxygen delivered with nasal cannula alone (night 4 [N4]). Oxygen flow
rates with and without DODS were adjusted the day before the first
night so that the resulting transcutaneous arterial oxygen saturation
(SaO2) was
95%. The following parameters
were evaluated each night: apnea-hypopnea index, nocturnal
SaO2, total oxygen saving, and several
neurophysiologic parameters.
Results: The oxygen
saving with the DODS was, on average, 60%. All parameters obtained
during N2 and N4 (oxygen alone) were identical. The percentage of total
recording time spent at SaO2
95% was
comparable between N2 ([mean ± SD]; 69 ± 32%) and N3
(61 ± 31%) (difference is not significant [NS]), as was the time
spent at SaO2 between 90% and 95% (N2,
29.8 ± 31%; N3, 35.9 ± 27%; NS) and < 90% (N2,
0.75 ± 2.6%; N3, 2.5 ± 8.6%; NS). Although the mean response
time was not significantly different between N2 and N3, two patients
experienced a substantial increase in response time with an
SaO2 < 90% on the DODS. The DODS device did
not induce any difference in the percentage of time spent in rapid eye
movement (REM) sleep (N2, 12.3 ± 8.7%; N3, 16.4 ± 7.8%; NS) or
non-REM sleep (N2, 87.7 ± 8.7%; N3, 83.7 ± 7.9%; NS). Non-REM
distribution in stage 12 sleep and in stage 34 sleep was comparable
between N2 and N3. Similarly, no difference was observed for the
sleep efficiency index (N2, 71 ± 15%; N3, 69.6 ± 14%; NS).
Differences between sleep onset latency times were NS.
Conclusions: In a majority of moderate to severe COPD patients, the use of a DODS device does not induce any significant alteration of nocturnal neurophysiologic and ventilatory profiles. However, the presence of nocturnal desaturation in a few patients justifies the need to systematically perform a ventilatory polygraphic recording when prescribing a DODS device.
Key Words: COPD demand oxygen delivery system nocturnal hypoventilation oxygen therapy
This article has been cited by other articles:
![]() |
A. Cuvelier, J.-F. Nuir, N. Chakroun, J. Aboab, G. Onea, and D. Benhamou Refillable Oxygen Cylinders May Be an Alternative for Ambulatory Oxygen Therapy in COPD* Chest, August 1, 2002; 122(2): 451 - 456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |